GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (ASX:MSB) » Definitions » Cyclically Adjusted FCF per Share

Mesoblast (ASX:MSB) Cyclically Adjusted FCF per Share : A$0.00 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Mesoblast Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mesoblast's adjusted free cash flow per share for the three months ended in Dec. 2023 was A$0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is A$0.00 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-10), Mesoblast's current stock price is A$1.045. Mesoblast's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was A$0.00. Mesoblast's Cyclically Adjusted Price-to-FCF of today is .


Mesoblast Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Mesoblast's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Cyclically Adjusted FCF per Share Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.23 -0.23 -0.23

Mesoblast Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -0.23 -0.22 - -

Competitive Comparison of Mesoblast's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Mesoblast's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesoblast's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mesoblast's Cyclically Adjusted Price-to-FCF falls into.



Mesoblast Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mesoblast's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0/126.3989*126.3989
=0.000

Current CPI (Dec. 2023) = 126.3989.

Mesoblast Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201306 0.000 95.473 0.000
201312 0.000 97.330 0.000
201406 0.000 98.352 0.000
201412 0.000 99.002 0.000
201503 0.000 99.187 0.000
201506 0.000 99.838 0.000
201509 -0.115 100.302 -0.145
201512 -0.073 100.673 -0.092
201603 -0.073 100.488 -0.092
201606 -0.061 100.859 -0.076
201609 -0.070 101.602 -0.087
201612 -0.086 102.159 -0.106
201703 -0.080 102.624 -0.099
201706 -0.069 102.809 -0.085
201709 -0.055 103.460 -0.067
201712 -0.039 104.110 -0.047
201803 -0.051 104.574 -0.062
201806 -0.054 104.945 -0.065
201809 -0.054 105.410 -0.065
201812 0.005 105.967 0.006
201903 -0.057 105.967 -0.068
201906 -0.052 106.617 -0.062
201909 -0.044 107.174 -0.052
201912 -0.005 107.917 -0.006
202003 -0.058 108.289 -0.068
202006 -0.037 106.246 -0.044
202009 -0.064 107.917 -0.075
202012 -0.001 108.846 -0.001
202103 -0.052 109.496 -0.060
202106 -0.037 110.332 -0.042
202109 -0.037 111.168 -0.042
202112 -0.037 112.654 -0.042
202203 -0.031 115.069 -0.034
202206 -0.029 117.112 -0.031
202209 -0.030 119.248 -0.032
202212 -0.031 121.477 -0.032
202303 -0.031 123.148 -0.032
202306 -0.029 124.170 -0.030
202309 -0.026 125.656 -0.026
202312 0.000 126.399 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Mesoblast  (ASX:MSB) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mesoblast Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Mesoblast's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesoblast (ASX:MSB) Business Description

Industry
Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Mesoblast (ASX:MSB) Headlines

From GuruFocus

Mesabi Trust Press Release

By Business Wire Business Wire 05-06-2020

Top 5 4th Quarter Trades of MAD RIVER INVESTORS

By GuruFocus Research GuruFocus Editor 02-06-2023

Mesabi Trust Press Release

By Business Wire 07-14-2023

Mesabi Trust Press Release

By Business Wire Business Wire 01-10-2022

Mesabi Trust Press Release

By Business Wire Business Wire 04-14-2023

Mesabi Trust Press Release

By Business Wire Business Wire 10-08-2021

Mesabi Trust Stock Appears To Be Significantly Overvalued

By GF Value GF Value 04-30-2021

Mesabi Trust Press Release

By Business Wire Business Wire 01-12-2023

Mesabi Trust Press Release

By Business Wire 01-12-2024